6533b822fe1ef96bd127cc4c
RESEARCH PRODUCT
COMPARATIVE EFFECTS OF ROSIGLITAZONE AND PIOGLITAZONE ON FASTING AND POSTPRANDIAL LDL-SIZE AND SUBCLASSES IN PATIENTS WITH TYPE-2 DIABETES
Christoph StettlerK. BerneisP. DiemEmanuel ChristManfredi RizzoBernard Chappuissubject
medicine.medical_specialtybusiness.industryGeneral MedicineType 2 diabetesmedicine.diseaseFasting glucosePostprandialEndocrinologyInternal medicineInternal Medicinerosiglitazone pioglitazone fasting glucose postprandial glucose LDL type-2 diabetesMedicineIn patientCardiology and Cardiovascular MedicinebusinessRosiglitazonePioglitazonemedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2008-05-01 | Atherosclerosis Supplements |